G1 Therapeutics, Inc. Human Resources Contracts & Agreements
49 Contracts & Agreements
- Bonus & Incentive Agreements (8 contracts)
- Compensation Agreements (4)
- Consulting Agreements (1)
- Employment Agreements (35)
- Separation Agreements (1)
- Second Amendment to Employment Agreement by and between Monica R. Thomas and the Registrant effective as of August 6, 2024 (Filed With SEC on August 8, 2024)
- Second Amendment to Employment Agreement by and between Andrew Perry and the Registrant effective as of (Filed With SEC on August 8, 2024)
- Third Amendment to Employment Agreement by and between Terry Murdock and the Registrant effective as of (Filed With SEC on August 8, 2024)
- Second Amendment to Employment Agreement by and between the Company and John Umstead V (Filed With SEC on August 7, 2024)
- Fourth Amendment to Employment Agreement by and between the Company and Rajesh K. Malik (Filed With SEC on August 7, 2024)
- Second Amendment to Employment Agreement by and between the Company and Mark Avagliano (Filed With SEC on August 7, 2024)
- Second Amendment to Employment Agreement by and between the Company and John E. Bailey, Jr (Filed With SEC on August 7, 2024)
- First Amendment to Employment Agreement by and between Monica R. Thomas and the Registrant effective as of April 1, 2024 (Filed With SEC on May 1, 2024)
- Second Amendment to Employment Agreement by and between Terry Murdock and the Registrant effective as of April 1, 2024 (Filed With SEC on May 1, 2024)
- Third Amendment to Employment Agreement by and between Rajesh Malik and the Registrant effective as of April 1, 2024 (Filed With SEC on May 1, 2024)
- First Amendment to Employment Agreement by and between Andrew Perry and the Registrant effective as of April 1, 2024 (Filed With SEC on May 1, 2024)
- First Amendment to Employment Agreement by and between Mark Avagliano and the Company effective as of April 1, 2024 (Filed With SEC on March 22, 2024)
- First Amendment to Employment Agreement by and between John W. Umstead V and the Company effective as of April 1, 2024 (Filed With SEC on March 22, 2024)
- First Amendment to Employment Agreement by and between John E. Bailey, Jr. and the Company effective as of April 1, 2024 (Filed With SEC on March 22, 2024)
- Employment Agreement by and between the Registrant and (Filed With SEC on February 28, 2024)
- Form of Restricted Stock Unit Agreement under the G1 Therapeutics, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan, as amended (Filed With SEC on February 28, 2024)
- Form of Restricted Stock Unit Agreement under the Amended and Restated 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (Filed With SEC on February 28, 2024)
- G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors (Filed With SEC on August 2, 2023)
- Form of Performance-Based Restricted Stock Unit Award Agreement under the Amended and Restated 2017 Employee, Director and Consultant Equity Plan (Filed With SEC on May 3, 2023)
- Employment Agreement by and between the Registrant and John W. Umstead V, dated as of February 28, 2023 (Filed With SEC on March 1, 2023)
- G1 Therapeutics, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan (Filed With SEC on May 4, 2022)
- G1 Therapeutics, Inc. 2021 Sales Force Inducement Equity Incentive Plan (Filed With SEC on November 3, 2021)
- Employment Agreement by and between Registrant and Andrew Perry dated July 28, 2021 (Filed With SEC on August 4, 2021)
- Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 21, 2021)
- G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on February 24, 2021)
- Employment Agreement by and between Registrant and John E. Bailey, Jr. dated September 29, 2020 (Filed With SEC on November 4, 2020)
- Employment Agreement by and between the Registrant and Soma Gupta dated March 12, 2020 (Filed With SEC on May 6, 2020)
- Employment Agreement by and between the Registrant and Mark Avagliano, dated as of July 29, 2019 (Filed With SEC on August 7, 2019)
- Separation and Transition Agreement by and between Registrant and Barclay Phillips, dated as of May 8, 2019 (Filed With SEC on August 7, 2019)
- Employment Agreement, by and between the Registrant and Terry Murdock, dated as of August 1, 2017, as amended; filed as Exhibit 10.1 to the Registrants Quarterly Report on Form... (Filed With SEC on June 13, 2019)
- Employment Agreement, by and between the Registrant and Rajesh K. Malik, M.D., dated July 1, 2014, as amended; First Amendment effective May 5, 2017, filed as Exhibit 10.5 to the... (Filed With SEC on June 13, 2019)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 13, 2019)
- Amended and Restated Employment Agreement by and between the Registrant and Jennifer K. Moses dated May 8, 2019 (Filed With SEC on May 9, 2019)
- Employment Agreement by and between the Registrant and John Demaree, dated as of July 3, 2018 (Filed With SEC on August 8, 2018)
- Employment Agreement by and between the Registrant and James S Hanson, dated as of June 25, 2018 (Filed With SEC on August 8, 2018)
- Employment Agreement between the Company and Barclay A. Phillips, effective as of November 13, 2017 (Filed With SEC on November 13, 2017)
- Employment Agreement by and between the Registrant and Terry Murdock, dated as of August 1, 2017 (Filed With SEC on November 8, 2017)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2017)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2017)
- G1 THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2017)
